BEGIN:VCALENDAR VERSION:2.0 PRODID:-//CiviCRM//NONSGML CiviEvent iCal//EN X-WR-TIMEZONE:Europe/London METHOD:PUBLISH BEGIN:VTIMEZONE TZID:Europe/London BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20260415T100000 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:CiviCRM_EventID_1955_e86a4f28f24ec85011f2b11344e0bb4c@onenucleus.com SUMMARY:Online Introduction to Drug Development – From Can didate Selection to Patients in Healthcare X-ALT-DESC;FMTTYPE=text/html:\n \n \n \n < td> \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
\n

\n \n

Online Introduction t o Drug Development: From Candidate Selection to Pa tients in Healthcare

\n
Audience\n

Those who want to understand what is done to bring new treatments to patients\, and/or better operate with the language of internal customers. T ypically people in non life-science technical role s in our sector – IT\, Finance\, HR and Admin staf f. Also helpful for early research professionals w ho wish to broaden their knowledge of later stage development.

\n 		 
Duration\n

A t hree-session online course

\n 		 
Objectives\n

This course generates understanding o f the range of activities that take a new candidat e drug molecule through Development\, Manufacturin g and Commercialization to routine patient use.  < br />\n
\n It is ideally designed to t ake up from the end point of the ‘Introduction to Drug Discovery’ course.
\n
\n The general industry structure (pharmaceutical\, biot echnology and vaccines) background is also explore d\; who are the players\, how big/small\, how do t hey interact with each other and with various serv ice organisations.

\n \n

It is a highly interactive\, clearly explained journey through:

\n \ n

- Technical development – making the molecule and the medicin e

\n \n

- Preclinical safety – ensuring drugs are saf e enough for patient use

\n \n

- Early clinical trial s – evaluating viability of new drugs

\n \n

- Integra ting healthcare with digital support and advanced diagnostics

\n \n

- Major trials and Regulatory – pro ving value and seeking license to market

\n \n

- Bran ding and commercialization for launch

\n \n

- Manufac turing and supply chain set up

\n \n

- Getting new tr eatments to patients worldwide

\n \n 		 
Costs \n

One Nucleus Gold: £392 + VAT
\n One Nucleus Silver: £476 + VAT
\n Non-me mbers: £560 + VAT

\n 		 
DESCRIPTION:\n \n \n \n \n \n \n Online Introduct ion to Drug Development: From Candidate Selection to Patients in Healthcare\n \n \n  \n \n \ n \n Audience\n \n Those who want to un derstand what is done to bring new treatments to p atients\, and/or better operate with the language of internal customers. Typically people in non lif e-science technical roles in our sector – IT\, Fin ance\, HR and Admin staff. Also helpful for early research professionals who wish to broaden their k nowledge of later stage development.\n \n \n \n  \n \n \n \n Duration\n \n A thre e-session online course\n \n \n \n  \n \n \n \n Objectives\n \n This course gener ates understanding of the range of activities that take a new candidate drug molecule through Develo pment\, Manufacturing and Commercialization to rou tine patient use.  \n \n \n \n It is ideally designed to take up from the end point of the ‘In troduction to Drug Discovery’ course.\n \n \n \ n The general industry structure (pharmaceutica l\, biotechnology and vaccines) background is also explored\; who are the players\, how big/small\, how do they interact with each other and with vari ous service organisations.\n \n \n \n It is a h ighly interactive\, clearly explained journey thro ugh:\n \n \n \n - Technical development – makin g the molecule and the medicine\n \n \n \n - Pr eclinical safety – ensuring drugs are safe enough for patient use\n \n \n \n - Early clinical tri als – evaluating viability of new drugs\n \n \n \n - Integrating healthcare with digital support and advanced diagnostics\n \n \n \n - Major tri als and Regulatory – proving value and seeking lic ense to market\n \n \n \n - Branding and commer cialization for launch\n \n \n \n - Manufacturi ng and supply chain set up\n \n \n \n - Getting new treatments to patients worldwide\n \n \n \ n  \n \n \n \n Costs\n \n One Nucl eus Gold: £392 + VAT\n \n One Nucleus Silver: £ 476 + VAT\n \n Non-members: £560 + VAT\n \n \n \n  \n \n \n \n CATEGORIES:Training CALSCALE:GREGORIAN DTSTAMP;TZID=Europe/London:20260415T100000 DTSTART;TZID=Europe/London:20260415T100000 DTEND;TZID=Europe/London:20260416T120000 LOCATION:ONLINE TRAINING TEAM - details will be sent to all registered delegates closer to the date of the ev ent\n United Kingdom\n URL:https://onenucleus.com/civicrm/event/info?reset=1&id=1955 END:VEVENT END:VCALENDAR